USA - NYSEARCA:RVP - US76129W1053 - Common Stock
The current stock price of RVP is 0.8363 USD. In the past month the price decreased by -13.58%. In the past year, price increased by 35.98%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 17.59 | 14.06B | ||
| SOLV | SOLVENTUM CORP | 12.09 | 12.45B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.29 | 10.02B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.74 | 5.23B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.51 | 3.45B | ||
| ICUI | ICU MEDICAL INC | 17.49 | 3.44B | ||
| HAE | HAEMONETICS CORP/MASS | 14.68 | 3.40B | ||
| XRAY | DENTSPLY SIRONA INC | 6.96 | 2.19B | ||
| UFPT | UFP TECHNOLOGIES INC | 27.18 | 1.81B | ||
| NEOG | NEOGEN CORP | 21.2 | 1.38B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.35B | ||
| EMBC | EMBECTA CORP | 4.68 | 799.56M |
Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. The company is headquartered in Little Elm, Texas and currently employs 221 full-time employees. The company went IPO on 2001-05-04. The firm is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
RETRACTABLE TECHNOLOGIES INC
511 Lobo Lane
Little Elm TEXAS 75068 US
CEO: Thomas J. Shaw
Employees: 224
Phone: 19722941010
Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. The company is headquartered in Little Elm, Texas and currently employs 221 full-time employees. The company went IPO on 2001-05-04. The firm is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.
The current stock price of RVP is 0.8363 USD. The price increased by 1.99% in the last trading session.
RVP does not pay a dividend.
RVP has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
RETRACTABLE TECHNOLOGIES INC (RVP) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
RETRACTABLE TECHNOLOGIES INC (RVP) has a market capitalization of 25.04M USD. This makes RVP a Nano Cap stock.
ChartMill assigns a technical rating of 5 / 10 to RVP. When comparing the yearly performance of all stocks, RVP is one of the better performing stocks in the market, outperforming 83.3% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to RVP. The financial health of RVP is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months RVP reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 50.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.1% | ||
| ROE | -11.73% | ||
| Debt/Equity | 0.01 |